肉瘤干细胞：我们知道自己在寻找什么吗？
Sarcoma stem cells: do we know what we are looking for?
作者信息
Trucco Matteo, Loeb David
机构信息
Division of Pediatric Oncology, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Bunting-Blaustein Cancer Research Building, Room 2M51, 1650 Orleans Street, Baltimore, MD 21231, USA.
出版信息
Sarcoma. 2012;2012:291705. doi: 10.1155/2012/291705. Epub 2012 May 9.
Abstract
Sarcomas represent a heterogeneous group of cancers thought to originate from malignant transformation of mesenchymal cells. There is increasing evidence that many, if not all, sarcomas contain within them tumor-initiating, or "cancer stem," cells responsible for the initiation, maintenance, and potentially relapse and metastasis of the tumor. Various techniques have been adopted in recent years to identify putative sarcoma stem cell populations. The goal of this paper is to summarize the criteria used to identify a stem cell population, describe the more prominent markers and techniques used to isolate cancer stem cells in sarcomas, and review the evidence for the existence of cancer stem cells in sarcomas.
摘要
肉瘤是一组异质性癌症，被认为起源于间充质细胞的恶性转化。越来越多的证据表明，即便不是所有的肉瘤，许多肉瘤都含有肿瘤起始细胞或“癌症干细胞”，这些细胞负责肿瘤的起始、维持，以及可能的复发和转移。近年来，人们采用了各种技术来鉴定假定的肉瘤干细胞群体。本文的目的是总结用于鉴定干细胞群体的标准，描述用于分离肉瘤中癌症干细胞的更突出的标志物和技术，并综述肉瘤中存在癌症干细胞的证据。
相似文献
1
Sarcoma stem cells: do we know what we are looking for?肉瘤干细胞：我们知道自己在寻找什么吗？
Sarcoma. 2012;2012:291705. doi: 10.1155/2012/291705. Epub 2012 May 9.
2
Sarcoma Stem Cell Heterogeneity.肉瘤干细胞异质性。
Adv Exp Med Biol. 2019;1123:95-118. doi: 10.1007/978-3-030-11096-3_7.
3
Do stem-like cells play a role in drug resistance of sarcomas?干细胞在肉瘤的耐药中发挥作用吗？
Expert Rev Anticancer Ther. 2010 Feb;10(2):261-70. doi: 10.1586/era.09.184.
4
The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.间充质干/祖细胞在肉瘤中的作用：最新进展与争议
Stem Cell Investig. 2014 Oct 27;1:18. doi: 10.3978/j.issn.2306-9759.2014.10.01. eCollection 2014.
5
Cancer Stem Cells in Soft-Tissue Sarcomas.软组织肉瘤中的癌症干细胞。
Cells. 2020 Jun 10;9(6):1449. doi: 10.3390/cells9061449.
6
Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells.克服骨肉瘤的治疗耐药性：骨肉瘤干细胞的分子机制与治疗靶点概述
Stem Cells Int. 2016;2016:2603092. doi: 10.1155/2016/2603092. Epub 2016 Dec 27.
7
Several types of soft tissue sarcomas originate from the malignant transformation of adipose tissue-derived stem cells.几种类型的软组织肉瘤起源于脂肪组织来源干细胞的恶性转化。
Mol Med Rep. 2010 May-Jun;3(3):441-8. doi: 10.3892/mmr_00000277.
8
Cancer stem cells in sarcomas: Getting to the stemness core.肉瘤中的癌症干细胞：探究干性核心。
Biochim Biophys Acta Gen Subj. 2018 Oct;1862(10):2134-2139. doi: 10.1016/j.bbagen.2018.07.006. Epub 2018 Jul 9.
9
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts.从肉瘤患者来源的异种移植瘤中分离和鉴定肿瘤起始细胞
J Vis Exp. 2019 Jun 13(148). doi: 10.3791/57011.
10
The Challenges of Detecting Circulating Tumor Cells in Sarcoma.肉瘤中循环肿瘤细胞检测面临的挑战
Front Oncol. 2016 Sep 7;6:202. doi: 10.3389/fonc.2016.00202. eCollection 2016.
引用本文的文献
1
Complex Interplay of Genes Underlies Invasiveness in Fibrosarcoma Progression Model.基因的复杂相互作用是纤维肉瘤进展模型侵袭性的基础。
J Clin Med. 2021 May 25;10(11):2297. doi: 10.3390/jcm10112297.
2
Biological Heterogeneity of Chondrosarcoma: From (Epi) Genetics through Stemness and Deregulated Signaling to Immunophenotype.软骨肉瘤的生物学异质性：从（表观）遗传学、干性及失调信号传导到免疫表型
Cancers (Basel). 2021 Mar 15;13(6):1317. doi: 10.3390/cancers13061317.
3
Acquisition of cancer stem cell capacities after spontaneous cell fusion.自发细胞融合后获得癌症干细胞能力。
BMC Cancer. 2021 Mar 7;21(1):241. doi: 10.1186/s12885-021-07979-2.
4
Establishment and Characterization of a Sclerosing Spindle Cell Rhabdomyosarcoma Cell Line with a Complex Genomic Profile.建立并鉴定具有复杂基因组特征的硬化性梭形细胞横纹肌肉瘤细胞系。
Cells. 2020 Dec 11;9(12):2668. doi: 10.3390/cells9122668.
5
Identification and editing of stem-like cells in methylcholanthrene-induced sarcomas.甲基胆蒽诱导的肉瘤中干细胞样细胞的鉴定与编辑
Oncoimmunology. 2018 Oct 31;8(1):e1404212. doi: 10.1080/2162402X.2017.1404212. eCollection 2019.
6
The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.间充质干/祖细胞在肉瘤中的作用：最新进展与争议
Stem Cell Investig. 2014 Oct 27;1:18. doi: 10.3978/j.issn.2306-9759.2014.10.01. eCollection 2014.
7
FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways.叉头框蛋白M1（FOXM1）在肉瘤中的作用：在细胞周期、多能性基因和干细胞通路中的作用
Oncotarget. 2016 Jul 5;7(27):42792-42804. doi: 10.18632/oncotarget.8669.
8
Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma.抗增殖而非抗血管生成的酪氨酸激酶抑制剂会使软组织肉瘤中的癌症干细胞富集。
BMC Cancer. 2014 Oct 10;14:756. doi: 10.1186/1471-2407-14-756.
9
An overview of the role of cancer stem cells in spine tumors with a special focus on chordoma.癌症干细胞在脊柱肿瘤中的作用概述，特别关注脊索瘤。
World J Stem Cells. 2014 Jan 26;6(1):53-64. doi: 10.4252/wjsc.v6.i1.53.
10
Cancer stem cells in pediatric sarcomas.儿童肉瘤中的癌症干细胞。
Front Oncol. 2013 Jun 27;3:168. doi: 10.3389/fonc.2013.00168. Print 2013.
本文引用的文献
1
STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH⁺/CD133⁺ stem cell-like human colon cancer cells.STAT3 信号通路对于 ALDH+/CD133+ 干细胞样人结肠癌细胞的细胞存活和肿瘤球形成能力是必需的。
Biochem Biophys Res Commun. 2011 Dec 16;416(3-4):246-51. doi: 10.1016/j.bbrc.2011.10.112. Epub 2011 Oct 31.
2
ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.ALDH 活性相对于 CD133 表达在人胰腺腺癌中选择性地定义了一个增强的肿瘤起始细胞群体。
PLoS One. 2011;6(6):e20636. doi: 10.1371/journal.pone.0020636. Epub 2011 Jun 13.
3
CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres.CD133 阳性胚胎横纹肌肉瘤干细胞样细胞群体在横纹球体中富集。
PLoS One. 2011;6(5):e19506. doi: 10.1371/journal.pone.0019506. Epub 2011 May 13.
4
Eyes wide open: a critical review of sphere-formation as an assay for stem cells.眼睛睁得大大的：球体形成作为干细胞检测方法的批判性评价。
Cell Stem Cell. 2011 May 6;8(5):486-98. doi: 10.1016/j.stem.2011.04.007.
5
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state.正常和肿瘤非干细胞可以自发地转化为干细胞样状态。
Proc Natl Acad Sci U S A. 2011 May 10;108(19):7950-5. doi: 10.1073/pnas.1102454108. Epub 2011 Apr 15.
6
Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.醛脱氢酶与 CD133 联合定义了血管生成性卵巢癌干细胞，预示着患者预后不良。
Cancer Res. 2011 Jun 1;71(11):3991-4001. doi: 10.1158/0008-5472.CAN-10-3175. Epub 2011 Apr 15.
7
Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.侧群细胞对于多形性胶质母细胞瘤中的癌症干细胞表型不是必需的或充分的。
Stem Cells. 2011 Mar;29(3):452-61. doi: 10.1002/stem.582.
8
Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo.人原发性骨肉瘤中存在 CD133+ 肿瘤干细胞，其在体内具有高致瘤性。
FASEB J. 2011 Jun;25(6):2022-30. doi: 10.1096/fj.10-179036. Epub 2011 Mar 8.
9
Metastatic potential of tumor-initiating cells in solid tumors.实体瘤中肿瘤起始细胞的转移潜能。
Front Biosci (Landmark Ed). 2011 Jan 1;16(5):1927-38. doi: 10.2741/3831.
10
High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition.高 ALDH 活性鉴定出对化疗耐药的尤文肉瘤干细胞，这些细胞对 EWS-FLI1 抑制仍保持敏感性。
PLoS One. 2010 Nov 11;5(11):e13943. doi: 10.1371/journal.pone.0013943.
Zotero 插件